Search Results 91-100 of 21520 for lupus
A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis ... lupus nephritis (LN) when ...
Inflammatory lung diseases, such as sarcoidosis. Mixed connective tissue disease. Sjogren syndrome. Systemic lupus erythematosus. Some healthy people — usually ...
Anifrolumab-fnia injection is used to treat moderate to severe systemic lupus erythematosus (SLE) in patients who are also receiving other lupus treatments.
These conditions include lupus, scleroderma and myositis. Many people who have mixed connective tissue disease also have inflammatory arthritis and Sjogren ...
Starting from the beginning may lead to better outcomes for lupus featured image. Health & Wellness. Starting from the beginning may lead to better outcomes ...
... lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) showing some skin symptoms. Participation eligibility. Participant eligibility includes age ...
A recent Mayo Clinic study highlights the link between glucocorticoid dosage and outcomes in patients with lupus nephritis, a type of kidney inflammation caused ...
In other findings, Mayo discovered a clue to why lupus tends to be worse in African-Americans; chronicled erratic blood pressure in rheumatoid arthritis ...
A recent Mayo Clinic study highlights the link between glucocorticoid dosage and outcomes in patients with lupus nephritis, a type of kidney inflammation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.